DIRECT SAMPLE ANALYSIS WITH AN ATMOSPHERIC PRESSURE GLOW DISCHARGE
利用大气压辉光放电进行直接样品分析
基本信息
- 批准号:7611686
- 负责人:
- 金额:$ 10.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-02-09 至 2010-02-08
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAddressAirAnodesAreaAtmospheric PressureBiochemicalBiologicalBiological AssayBiological SciencesBiomedical ResearchCathodesCellsCellular StructuresCharacteristicsChargeChemicalsClinicalCouplingCytochrome P450DetectionDevelopmentDiffuseElectrodesElectronsElectrospray IonizationEnvironmentHandIACUCImageIn VitroIndianaIonsLaboratoriesLasersLateralLettersLibrariesMarketingMass Spectrum AnalysisMeasurementMeasuresMedicalMethodsModificationNatureNephrologyNeurologyPerformancePharmacologic SubstancePhasePlasmaPreparationProceduresReagentResearch Ethics CommitteesResolutionSamplingSchemeScreening procedureSmall Business Technology Transfer ResearchSourceSpatial DistributionSpottingsStructureSurfaceSystemTechniquesTechnologyTemperatureTimeTissuesUniversitiesbasecombinatorialcommercializationdensitydesignhigh throughput screeningin vivoinnovationinstrumentationinterestion mobilityion sourceionizationionization techniquemass spectrometermedical schoolsmolecular imagingnew technologyoncologyplanetary Atmospherepre-clinicalprototypepublic health relevancetool
项目摘要
DESCRIPTION (provided by applicant): The overall objective of this Phase I STTR project is the commercialization of a new ionization source for ambient mass spectrometry based on the flowing afterglow of an atmospheric pressure glow discharge (APGD). This technology promises to have significant impact in pharmaceutical, clinical and biomedical research and its potential for enabling in vivo mass spectrometry detection in combination with existing technology is real. There is an acute need for the development of new technologies which enable rapid measurements with minimal sample pretreatment. Minimizing up-front sample preparation increases sample through-put by reducing the time required to go from raw material to a result. The recent development of ambient mass spectrometry methods has already resulted in the successful commercialization of just a few of these disruptive technologies. This project involves the fundamental characterization, optimization and development of a new direct sampling technology for mass spectrometry based on the flowing afterglow of an atmospheric pressure glow discharge developed at Indiana University by Prof. Gary Heiftje. Atmospheric pressure glow discharges have been extensively studied but not until very recently has it been attempted to use an atmospheric pressure glow discharge for direct sampling of surfaces in the open ambient air. We envision commercial ion sources that can be easily converted among several atmospheric pressure ionization techniques and can be retro-fitted to several different types of mass spectrometers or ion mobility spectrometers. The specific aims of this Phase I STTR proposal are: Aim 1: Investigate the APGD and flowing afterglow chemical environment using spectroscopic techniques. Aim 2: Identify electrode structures and materials for the anode and cathode in an attempt to optimize the atmospheric glow discharge characteristics using the information gained through completion of Aim 1. An "optimized" cell will be one which maximizes reagent ion density and controls their spatial distribution. Aim 3: Operate the APGD cell in combination with mass spectrometry and identify operating conditions for the cell geometries investigated in Aim 2. Aim 4: Assess the feasibility for coupling APGD to a commercial laser ablation mass spectrometry system. Phase II of this project will include the development of a commercial prototype of the APGD ion source based on the criteria defined in Phase I, further optimization of its performance and robustness, comparisons to other ambient ionization methods and applications development in the areas of pharmaceutical and biomedical research. Specifically, Phase II will focus in part on the development of the APGD cell in combination with commercially available laser ablation mass spectrometry systems, which will enable direct, 3D molecular imaging of biological tissues. Other application areas that will be explored with the same instrumentation include high throughput screening of combinatorial libraries and in vitro cytochrome P450 assays. PUBLIC HEALTH RELEVANCE: Prosolia's new and versatile ambient ionization source for mass spectrometry promises to enable high throughput chemical screening that will significantly impact pharmaceutical, clinical and biomedical research.
描述(由申请人提供):I阶段ISTTR项目的总体目标是基于大气压力释放(APGD)的流动余辉的环境质谱新的电离源的商业化。这项技术有望在药物,临床和生物医学研究中产生重大影响,及其在与现有技术结合使用体内质谱检测的潜力是真实的。急需开发新技术,可以通过最少的样品预处理进行快速测量。通过减少从原材料到结果所需的时间来最大程度地减少前期样品制备,从而增加了样本。环境质谱法的最新发展已经导致了仅一些破坏性技术的成功商业化。该项目涉及基于Gary Heiftje教授在印第安纳大学开发的大气压力发光的流动余辉的基本表征,优化和开发用于质谱的新直接采样技术。大气压力发光的放电已经进行了广泛的研究,但直到最近才尝试使用大气压力放电来直接对开放环境空气中的表面进行直接采样。我们设想可以在几种大气压力电离技术中轻松转换的商业离子源,并且可以重新安装到几种不同类型的质谱仪或离子迁移率光谱仪上。该阶段ISTTR建议的具体目的是:目标1:使用光谱技术研究APGD和流动的余辉环境。 AIM 2:通过通过完成AIM 1获得的信息来优化阳极和阴极的电极结构和材料,以优化大气发光放电特性。“优化”的细胞将是最大化试剂离子密度并控制其空间分布的细胞。 AIM 3:与质谱结合使用APGD细胞,并确定AIM 2中研究的细胞几何形状的工作条件。AIM4:评估将APGD耦合到商业激光消融质谱系统的可行性。该项目的第二阶段将包括基于第一阶段定义的标准,其性能和鲁棒性的进一步优化的APGD离子源的商业原型,与其他环境电离方法的比较以及在药物和生物医学研究领域中的其他环境电离方法的开发。具体而言,第二阶段将重点关注APGD细胞的开发以及市售激光消融质谱系统,该系统将启用生物组织的直接3D分子成像。将使用相同仪器探索的其他应用区域包括组合库的高吞吐量筛选和体外细胞色素P450分析。 公共卫生相关性:Prosolia的质谱法新的和多功能的环境电离源有望实现高吞吐性化学筛查,这将显着影响药物,临床和生物医学研究。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ultrasensitive ambient mass spectrometric analysis with a pin-to-capillary flowing atmospheric-pressure afterglow source.
- DOI:10.1021/ac201053q
- 发表时间:2011-07-15
- 期刊:
- 影响因子:7.4
- 作者:Shelley, Jacob T.;Wiley, Joshua S.;Hieftje, Gary M.
- 通讯作者:Hieftje, Gary M.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Justin Michael Wiseman其他文献
Justin Michael Wiseman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Justin Michael Wiseman', 18)}}的其他基金
All-in-one Device for Forensic Toxicology Drug Screening
用于法医毒理学药物筛选的一体化设备
- 批准号:
10482653 - 财政年份:2022
- 资助金额:
$ 10.2万 - 项目类别:
All-in-one Device for Forensic Toxicology Drug Screening
用于法医毒理学药物筛选的一体化设备
- 批准号:
10743053 - 财政年份:2022
- 资助金额:
$ 10.2万 - 项目类别:
DEVELOPMENT OF AN INTELLIGENT SAMPLE INTRODUCTION SYSTEM FOR MASS SPECTROMETRY
质谱智能进样系统的开发
- 批准号:
8590085 - 财政年份:2013
- 资助金额:
$ 10.2万 - 项目类别:
Development of a Novel Atmospheric Pressure Glow Discharge for Ambient Mass Spect
用于环境质谱的新型大气压辉光放电的开发
- 批准号:
8301546 - 财政年份:2009
- 资助金额:
$ 10.2万 - 项目类别:
Development of a Novel Atmospheric Pressure Glow Discharge for Ambient Mass Spect
用于环境质谱的新型大气压辉光放电的开发
- 批准号:
8198467 - 财政年份:2009
- 资助金额:
$ 10.2万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Functional, structural, and computational consequences of NMDA receptor ablation at medial prefrontal cortex synapses
内侧前额皮质突触 NMDA 受体消融的功能、结构和计算后果
- 批准号:
10677047 - 财政年份:2023
- 资助金额:
$ 10.2万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 10.2万 - 项目类别:
LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
LRP1 作为成体神经干细胞和中风后反应中 CXCR4 的新型调节剂
- 批准号:
10701231 - 财政年份:2023
- 资助金额:
$ 10.2万 - 项目类别:
Mechanisms of Cardiac Injury Resolution by CX3CR1+ Macrophages
CX3CR1巨噬细胞解决心脏损伤的机制
- 批准号:
10719459 - 财政年份:2023
- 资助金额:
$ 10.2万 - 项目类别:
Investigating cerebrovascular dysfunction and cerebral atrophy in severe traumatic brain injury
严重颅脑损伤中脑血管功能障碍和脑萎缩的调查
- 批准号:
10742569 - 财政年份:2023
- 资助金额:
$ 10.2万 - 项目类别: